Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Resident Memory CD8+ T Cells Within Cancer Islands Mediate Survival in Breast Cancer Patients

JCI insight
Medicine
2019English

Using Epigenetics to Define Vaccine-Induced Memory T Cells

Current Opinion in Virology
Virology
2013English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

Resident Memory T Cells in Mouse and Human

Japanese Journal of Clinical Immunology
2016English

The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Redirecting Mouse T Hybridoma Against Human Breast and Ovarian Carcinomas: In Vivo Activity Against HER-2/neu Expressing Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2003English

Memory CD8+ T Cells in HIV Infection

Philosophical Transactions of the Royal Society B: Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2000English

CD40 Ligand-Expressing Recombinant Vaccinia Virus Promotes the Generation of CD8+ Central Memory T Cells

European Journal of Immunology
AllergyImmunology
2015English

Analysis of Vaccine-Induced T Cells in Humans With Cancer

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy